TNYA · Categories · Form 4

TNYA - SEC Form 4 insider transactions

Tenaya Therapeutics Inc. (TNYA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TNYA

• 5d
  SEC Form 4 filed by Director Williams R Sanders

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 5d
  SEC Form 4 filed by Director Walsh Jeffrey T.

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 5d
  SEC Form 4 filed by Director Stehman-Breen Catherine

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 5d
  SEC Form 4 filed by Director Srivastava Deepak

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 5d
  SEC Form 4 filed by Director Parschauer Karah Herdman

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 5d
  SEC Form 4 filed by Director Lee June

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 5d
  SEC Form 4 filed by Director Burroughs Amy L.

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 15d
  Chief Executive Officer Ali Faraz sold $2,690 worth of shares (3,390 units at $0.79), decreasing direct ownership by 0.76% to 440,014 units (SEC Form 4) (tax withholding)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 15d
  Chief Medical Officer Tingley Whittemore sold $2,477 worth of shares (3,121 units at $0.79), decreasing direct ownership by 1% to 215,497 units (SEC Form 4) to cover taxes

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 15d
  SVP, Finance Higa Tomohiro sold $1,178 worth of shares (1,485 units at $0.79), decreasing direct ownership by 1% to 118,267 units (SEC Form 4) to cover taxes

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 97d
  Large owner Column Group Iii Gp, Lp sold $2,380,189 worth of shares (4,170,266 units at $0.57) (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 99d
  Large owner Column Group Iii Gp, Lp sold $504,787 worth of shares (829,734 units at $0.61) (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 106d
  SVP, Finance Higa Tomohiro sold $2,231 worth of shares (3,469 units at $0.64), decreasing direct ownership by 3% to 119,752 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 106d
  Chief Executive Officer Ali Faraz sold $9,557 worth of shares (14,862 units at $0.64), decreasing direct ownership by 3% to 443,404 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 106d
  Chief Medical Officer Tingley Whittemore sold $3,319 worth of shares (5,160 units at $0.64), decreasing direct ownership by 2% to 218,618 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 111d
  Large owner Column Group Iii Gp, Lp sold $3,042,222 worth of shares (4,400,290 units at $0.69) (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 118d
  SVP, Finance Higa Tomohiro was granted 29,250 shares, increasing direct ownership by 31% to 123,221 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 118d
  Chief Medical Officer Tingley Whittemore was granted 48,750 shares, increasing direct ownership by 28% to 223,778 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 118d
  Chief Executive Officer Ali Faraz was granted 158,600 shares, increasing direct ownership by 53% to 458,266 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 198d
  SVP, Finance Higa Tomohiro sold $1,818 worth of shares (1,367 units at $1.33), decreasing direct ownership by 1% to 93,971 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 198d
  Chief Medical Officer Tingley Whittemore sold $3,826 worth of shares (2,877 units at $1.33), decreasing direct ownership by 2% to 169,926 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 198d
  Chief Executive Officer Ali Faraz sold $4,158 worth of shares (3,126 units at $1.33), decreasing direct ownership by 1% to 299,666 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 289d
  SVP, Finance Higa Tomohiro sold $3,711 worth of shares (2,962 units at $1.25), decreasing direct ownership by 3% to 95,338 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 289d
  Chief Medical Officer Tingley Whittemore sold $6,331 worth of shares (5,053 units at $1.25), decreasing direct ownership by 3% to 172,803 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 289d
  Chief Executive Officer Ali Faraz sold $18,210 worth of shares (14,533 units at $1.25), decreasing direct ownership by 5% to 302,792 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 369d
  SEC Form 4 filed by Director Stehman-Breen Catherine

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 369d
  SEC Form 4 filed by Director Walsh Jeffrey T.

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 369d
  SEC Form 4 filed by Director Burroughs Amy L.

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 369d
  SEC Form 4 filed by Director Goeddel David V

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 369d
  SEC Form 4 filed by Director Williams R Sanders

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 369d
  SEC Form 4 filed by Director Srivastava Deepak

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 369d
  SEC Form 4 filed by Director Lee June

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 369d
  SEC Form 4 filed by Director Parschauer Karah Herdman

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 383d
  SVP, Finance Higa Tomohiro sold $615 worth of shares (1,390 units at $0.44), decreasing direct ownership by 1% to 98,300 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 383d
  Chief Medical Officer Tingley Whittemore sold $1,300 worth of shares (2,937 units at $0.44), decreasing direct ownership by 2% to 171,856 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 383d
  Chief Executive Officer Ali Faraz sold $1,412 worth of shares (3,189 units at $0.44), decreasing direct ownership by 0.99% to 317,325 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 450d
  SVP, Finance Higa Tomohiro sold $1,336 worth of shares (2,482 units at $0.54), decreasing direct ownership by 2% to 99,690 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 450d
  Chief Medical Officer Tingley Whittemore sold $3,983 worth of shares (7,398 units at $0.54), decreasing direct ownership by 4% to 174,793 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 450d
  Chief Executive Officer Ali Faraz sold $5,245 worth of shares (9,741 units at $0.54), decreasing direct ownership by 3% to 320,514 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 481d
  Chief Executive Officer Ali Faraz was granted 141,924 shares, increasing direct ownership by 75% to 330,255 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 491d
  Chief Medical Officer Tingley Whittemore was granted 71,676 shares, increasing direct ownership by 67% to 178,782 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 562d
  SVP, Accounting and Fin. Ops. Saito Chihiro sold $4,787 worth of shares (2,258 units at $2.12), decreasing direct ownership by 4% to 60,983 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 590d
  SEC Form 4 filed by Director Walsh Jeffrey T.

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 590d
  SEC Form 4 filed by Director Williams R Sanders

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 590d
  SEC Form 4 filed by Director Stehman-Breen Catherine

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 590d
  SEC Form 4 filed by Director Srivastava Deepak

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 590d
  SEC Form 4 filed by Director Parschauer Karah Herdman

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 590d
  SEC Form 4 filed by Director Lee June

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 590d
  SEC Form 4 filed by Director Goeddel David V

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 590d
  SEC Form 4 filed by Director Burroughs Amy L.

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 653d
  SVP, Accounting and Fin. Ops. Saito Chihiro was granted 25,000 shares and sold $6,840 worth of shares (2,363 units at $2.89), increasing direct ownership by 56% to 63,241 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 656d
  Chief Medical Officer Tingley Whittemore sold $21,500 worth of shares (7,428 units at $2.89), decreasing direct ownership by 6% to 107,106 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 656d
  Chief Executive Officer Ali Faraz sold $28,216 worth of shares (9,748 units at $2.89), decreasing direct ownership by 5% to 188,331 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 819d
  Hoey Timothy sold $23,101 worth of shares (3,300 units at $7.00), decreasing direct ownership by 1% to 245,346 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 827d
  Hoey Timothy was granted 12,500 shares, increasing direct ownership by 5% to 248,646 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 827d
  Tingley Whittemore was granted 35,000 shares, increasing direct ownership by 48% to 108,534 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 827d
  Patterson Leone D was granted 35,000 shares, increasing direct ownership by 58% to 95,755 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 827d
  Ali Faraz was granted 85,000 shares, increasing direct ownership by 75% to 198,079 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 833d
  Hoey Timothy sold $35,046 worth of shares (6,569 units at $5.34), decreasing direct ownership by 3% to 236,146 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)
• 838d
  Hoey Timothy sold $27,431 worth of shares (4,681 units at $5.86), decreasing direct ownership by 2% to 242,715 units (SEC Form 4)

  4 - Tenaya Therapeutics, Inc. (0001858848) (Issuer)

Other TNYA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends